Actelion Pharmaceuticals $65M Tracleer, Bosentan Settlement
Court case: Government Employees Health Association v. Actelion Pharmaceuticals Ltd., et al.
Actelion Pharmaceuticals agreed to pay $65 million to resolve claims that it blocked generic competition for the drug Tracleer (bosentan). The deal covered health insurers and other third-party payors that bought or reimbursed the drug from December 29, 2015 through September 6, 2024, not individual patients. The claim filing window has closed.
Official eligibility wordingThird-party payors (health insurers, HMOs, self-insured plans) that purchased, paid, or reimbursed Tracleer or bosentan for members/employees/insureds in specified states from December 29, 2015 through September 6, 2024. Individual consumers are not part of this lawsuit. Checked against the official settlement source by SettleSignal on June 19, 2026.
Key facts
- Who may qualify This settlement was for third-party payors only, such as health insurers, HMOs, and self-insured health plans that purchased, paid for, or reimbursed Tracleer or bosentan for their members or employees. Individual consumers who took the drug were not part of this case.
- Claim deadlineAugust 3, 2026 (closed)
- Objection deadlineJune 2, 2026 (passed)
- Proof requiredYes
- What you needThe claim deadline passed on August 3, 2026, and no new claims are being accepted.
- CourtUnited States District Court for the District of Maryland
What you'll need to file
From our inspection of the official claim form:
- Filing method Online or mail-in
- Notice ID Unknown
How hard is this claim to file?
What the form asks
- — Legal name of the third-party payor organization filing the claim (Your organization's legal registration or plan documents)
- — National Drug Code (NDC) number and the drug name (Tracleer or bosentan) for each transaction (Pharmacy claims data, explanation of benefits (EOB) records, or pharmacy benefit manager reports)
- — The date each prescription was filled or purchased (Pharmacy claims data or EOB records)
- — State where the purchase occurred and state where the insured or beneficiary is located (Claims data; for mail-order, use the state where the medication was received)
- — The net dollar amount your organization actually paid for each transaction after subtracting member cost-sharing (Pharmacy claims data or PBM reports showing plan-paid amounts)
- — The plan or group name and Federal Employer Identification Number for each entity on whose behalf the agent is filing (Plan documents or employer tax records)
Documents you'll need
Watch out for
- Individual consumers who purchased the drug for personal use are excluded and cannot file a claim
- Government entities and subsidiaries or affiliates of the defendants are also excluded
- Mail-order purchases are considered to have occurred in the state where the medication was received, not where the pharmacy is located — verify the correct state for each transaction
- Agents filing on behalf of multiple entities must provide written authorization for each entity and include the plan or group name and FEIN per transaction
- The settlement administrator may request additional information or documents if needed, so retain all supporting records
- Payments are distributed only after the court grants final approval and any appeals are resolved — there is no fixed payout date yet
We prepare — you file on the official site yourself. This is not legal advice and is not an eligibility decision; the administrator and court decide.
Verify it yourself
How we verified this record
- Claim deadline
- Eligibility
- Proof requirement
- Administrator
- Official claim link
- Court case
- Payment status
- 1 field queued for re-check
1 official source linked to this record.
-
Claim deadline
August 3, 2026
-
Eligibility summary Quoted in the official eligibility wording above ↑
-
Proof requirement
Yes
A Third-Party Payor ("TPP"), or an authorized agent can complete this Claim Form. Individual consumers are not part of this lawsuit.
-
Payment status
Final approval pending
Payments will be made to those who qualify only after the Court approves the Settlement and any appeals are resolved.
-
Administrator
AB Data
-
Court
United States District Court for the District of Maryland
Show all 6 more verified fields
-
Official claim URL
tracleerlitigation.com
-
Objection deadline
June 2, 2026
-
Class period start
December 29, 2015
-
Class period end
September 6, 2024
-
Court case number
GLR-18-3560
-
Case name
Government Employees Health Association v. Actelion Pharmaceuticals Ltd., et al.
Where to act
Status history
- Claim deadline passed.
- Settlement published after verification.
- Verified field details updated from an official source.